Alyeska Investment Group’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Hold |
0
| – | – | – | 571 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 556 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 571 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 575 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 608 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 606 |
|
|
2016
Q4 | – | Sell |
-5,571
| Closed | -$554K | – | 601 |
|
|
2016
Q3 | $554K | Buy |
+5,571
| New | +$554K | 0.01% | 416 |
|
|
2016
Q1 | – | Sell |
-10,107
| Closed | -$467K | – | 516 |
|
|
2015
Q4 | $467K | Buy |
10,107
+2,906
| +40% | +$134K | 0.01% | 347 |
|
|
2015
Q3 | $694K | Buy |
7,201
+572
| +9% | +$55.1K | 0.01% | 401 |
|
|
2015
Q2 | $908K | Sell |
6,629
-1,223
| -16% | -$168K | 0.01% | 391 |
|
|
2015
Q1 | $1.4M | Buy |
7,852
+2,817
| +56% | +$502K | 0.02% | 384 |
|
|
2014
Q4 | $1.01M | Buy |
5,035
+1,063
| +27% | +$213K | 0.02% | 382 |
|
|
2014
Q3 | $799K | Sell |
3,972
-2,790
| -41% | -$561K | 0.02% | 324 |
|
|
2014
Q2 | $1.09M | Buy |
6,762
+1,033
| +18% | +$166K | 0.02% | 312 |
|
|
2014
Q1 | $1.15M | Buy |
+5,729
| New | +$1.15M | 0.03% | 244 |
|